GrapheneDx, General Graphene Corp and Sapphiros Enter Into Strategic Partnership to Industrialize Graphene-Based Biosensors to Revolutionize Point of Care and Consumer Diagnostics

BOSTON and KNOXVILLE, Tenn., Jun. 6, 2023 /PRNewswire/ — Today, GrapheneDxTM, General Graphene Corporation and SapphirosTM announce a strategic partnership to industrialize graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point-of-care and in consumer settings. GrapheneDx is an in vitro diagnostics company focused on improving diagnostic capability at the […]